- Active Pharmaceutical Ingredients
- 酒石酸伐尼克兰
- Aprepitant, Fosapitant Intermediates
- 福沙匹坦双葡甲胺
- 维格列汀
- 艾氟康唑
- Luliconazole Intermediate
- 钆特酸葡胺
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- 酒石酸伐尼克兰
- 阿瑞匹坦 287930-73-8
- 阿瑞匹坦 127852-28-2
- 阿瑞匹坦 287930-75-0
- 阿瑞匹坦 200000-59-5
- 阿瑞匹坦 155742-64-6
- 阿瑞匹坦 252742-72-6
- 福沙匹坦双葡甲胺 990-91-0
- 福沙匹坦双葡甲胺 265121-01-5
- 维格列汀 207557-35-5
- 维格列汀 702-82-9
- 艾氟康唑 144230-50-2
- 艾氟康唑 133775-25-4
- 艾氟康唑 127000-90-2
- 钆特酸葡胺
- 米拉贝隆
- 卢立康唑 98873-55-3
- 卢立康唑 126534-31-4
- 硫酸阿扎那韦
- 硼替佐米 179324-87-9
- 硼替佐米 114457-94-2
- 硼替佐米 205393-22-2
- 布林佐胺
- 利伐沙 446292-08-6
- 利伐沙 446292-07-5
- 西那卡塞 1005450-55-4
- 西那卡塞 585-50-2
- Eletriptan Intermediate
- 茚达特罗 312753-53-0
- 茚达特罗 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Diabetes medication Linagliptin 668270-12-0
【Catalog number】AP4700
【CAS #】668270-12-0
【Molecular formula】C16H20F6N5O6P
【Product Brief】US-DMF No. 29692 Lilaliptin, English name Linagliptin, American Chemical Abstracts registration number cas 668270-12-0.
English Name :
Linagliptin
CAS# :
668270-12-0
产品描述
[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[产品参数, 参数]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]
Linagliptin
CAS 668270-12-0
US-DMF No. 29692
Alias 8-[(3R) -3-amino-1-piperidinyl] -7- (2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl- 2-quinazolinyl) methyl] -1H-purine-2,6-dione
Catalog number AP4700
CAS # 668270-12-0
Molecular formula C25H28N8O2
Molecular weight 472.54
Structural formula
Product introduction
CAS 668270-12-0
US-DMF No. 29692 Lilaliptin, English name Linagliptin, American Chemical Abstracts registration number cas 668270-12-0.
Lillaritin (cas 668270-12-0) was approved by the FDA on May 2, 2011 to improve dietary and exercise control of blood glucose levels in people with type 2 diabetes. Lilaridine improves patients' glycemic control by inhibiting dipeptidyl peptidase-4 (DPP-4).
扫二维码用手机看
VIWIT 沪ICP备12014533号-1
